HemaSphere (Jun 2022)

PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE.

  • C. Giatra,
  • E. Souravla,
  • I. Darmani,
  • A. Roumelioti,
  • K. Kaouranis,
  • P. Kosmas,
  • V. Bampali,
  • D. Gardeli,
  • M. Papageorgiou,
  • Z. Mellios,
  • F. Karaolidou,
  • I. Tsonis,
  • M. Karatza,
  • K. George,
  • L. Marinos,
  • D. Karakasis,
  • T. Karmiris,
  • M. Bakiri,
  • M. Bouzani

DOI
https://doi.org/10.1097/01.HS9.0000851232.61292.37
Journal volume & issue
Vol. 6
pp. 1971 – 1972

Abstract

Read online

No abstracts available.